首页 > 最新文献

The Lancet. Respiratory medicine最新文献

英文 中文
Prevalence of sleep-disordered breathing in an African general population: The Benin Society and Sleep (BeSAS) study. 非洲普通人群中睡眠呼吸障碍的患病率:贝宁社会与睡眠(BeSAS)研究。
Pub Date : 2022-04-01 DOI: 10.2139/ssrn.3963785
A. Wachinou, Corinne Houehanou, S. Ade, T. Totah, M. Berger, G. Solelhac, S. Amidou, Attanon Arnauld Fiogbe, F. Alovokpinhou, Philipe Lacroix, P. Preux, P. Marques-Vidal, G. Agodokpessi, D. Houinato, R. Heinzer
BACKGROUNDData on the prevalence of sleep-disordered breathing (SDB) in the African general population are scarce, and a better understanding is urgently needed. Our study aimed to objectively determine the prevalence of, and factors associated with, SDB in a large sample in Benin, west Africa.METHODSIn the Benin Society and Sleep (BeSAS) cross-sectional study, participants aged 25 years and older were recruited from both urban and rural areas. Rural participants were recruited from Tanve, a village located 200 km north of Cotonou, and urban participants were recruited from Cotonou. The participants underwent respiratory polygraphy at home using a type-3 device that measures airflow through a nasal pressure sensor, respiratory effort (thoracic movement), and pulse oximetry. Clinical and morphometric data were also collected. SDB severity categories were defined according to the apnoea-hypopnoea index (AHI), with mild-to-severe SDB (AHI ≥5/h), moderate-to-severe SDB (AHI ≥15/h), and severe SDB (AHI ≥30/h).FINDINGSThe study was completed from April 4, 2018 to Jan 15, 2021. Of 2909 participants recruited in the BeSAS study, 2168 (74·5%) underwent respiratory polygraphy. For the 1810 participants with complete polygraphic data (mean age 46 years, SD 15; 1163 [64·2%] women), the prevalence of mild-to-severe SDB (AHI ≥5/h) was 43·2% (95% CI 40·9-45·5), of moderate-to-severe SDB (AHI ≥15/h) was 11·6% (10·2-13·1), and of severe SDB (AHI ≥30/h) was 2·7% (2·0-3·5). Factors independently associated with SDB were advanced age, male sex, large neck circumference, abdominal obesity, overweight or obesity, and snoring. After multivariable adjustment, severe SDB was independently associated with hypertension in women (odds ratio 3·99, 95% CI 1·04-15·33; ptrend=0·044), but not in men (odds ratio 0·67, 0·22-2·05; Ptrend=0·63).INTERPRETATIONThe BeSAS study provides the first large-scale objective evaluation of SDB prevalence and associated factors in Africa. The high prevalence of SDB identified should stimulate the development of public health policies to prevent and treat this condition in African countries.FUNDINGLigue Pulmonaire Vaudoise, Switzerland.
背景:关于非洲普通人群中睡眠呼吸障碍(SDB)患病率的数据很少,迫切需要更好的了解。我们的研究旨在客观地确定西非贝宁大样本中SDB的患病率及其相关因素。方法在贝宁社会与睡眠(BeSAS)横断面研究中,从城市和农村地区招募年龄在25岁及以上的参与者。农村参与者从科托努以北200公里的Tanve村招募,城市参与者从科托努招募。参与者在家中使用3型设备进行呼吸测谎,该设备通过鼻压力传感器测量气流、呼吸力度(胸部运动)和脉搏血氧仪。同时收集临床和形态计量学数据。根据呼吸暂停-呼吸不足指数(AHI)定义SDB严重程度分类,分为轻至重度(AHI≥5/h)、中至重度(AHI≥15/h)和重度(AHI≥30/h)。研究于2018年4月4日至2021年1月15日完成。在BeSAS研究中招募的2909名参与者中,2168名(77.5%)接受了呼吸测谎。对于1810名具有完整测谎数据的参与者(平均年龄46岁,标准差15;其中,轻重度SDB (AHI≥5/h)患病率为43.2% (95% CI 40.9 ~ 45.5),中重度SDB (AHI≥15/h)患病率为11.6%(10.2 ~ 13.1),重度SDB (AHI≥30/h)患病率为2.7%(2.0 ~ 3.5)。与SDB独立相关的因素有高龄、男性、颈围大、腹部肥胖、超重或肥胖、打鼾。多变量调整后,重度SDB与女性高血压独立相关(优势比3.99,95% CI 1.04 - 15.33;p趋势= 0.044),但男性没有(优势比0.67,0.22 - 2.05;Ptrend = 0·63)。BeSAS研究首次提供了非洲SDB患病率及其相关因素的大规模客观评估。已确定的SDB的高患病率应刺激非洲国家制定公共卫生政策,以预防和治疗这种疾病。基金:法国大学,瑞士。
{"title":"Prevalence of sleep-disordered breathing in an African general population: The Benin Society and Sleep (BeSAS) study.","authors":"A. Wachinou, Corinne Houehanou, S. Ade, T. Totah, M. Berger, G. Solelhac, S. Amidou, Attanon Arnauld Fiogbe, F. Alovokpinhou, Philipe Lacroix, P. Preux, P. Marques-Vidal, G. Agodokpessi, D. Houinato, R. Heinzer","doi":"10.2139/ssrn.3963785","DOIUrl":"https://doi.org/10.2139/ssrn.3963785","url":null,"abstract":"BACKGROUND\u0000Data on the prevalence of sleep-disordered breathing (SDB) in the African general population are scarce, and a better understanding is urgently needed. Our study aimed to objectively determine the prevalence of, and factors associated with, SDB in a large sample in Benin, west Africa.\u0000\u0000\u0000METHODS\u0000In the Benin Society and Sleep (BeSAS) cross-sectional study, participants aged 25 years and older were recruited from both urban and rural areas. Rural participants were recruited from Tanve, a village located 200 km north of Cotonou, and urban participants were recruited from Cotonou. The participants underwent respiratory polygraphy at home using a type-3 device that measures airflow through a nasal pressure sensor, respiratory effort (thoracic movement), and pulse oximetry. Clinical and morphometric data were also collected. SDB severity categories were defined according to the apnoea-hypopnoea index (AHI), with mild-to-severe SDB (AHI ≥5/h), moderate-to-severe SDB (AHI ≥15/h), and severe SDB (AHI ≥30/h).\u0000\u0000\u0000FINDINGS\u0000The study was completed from April 4, 2018 to Jan 15, 2021. Of 2909 participants recruited in the BeSAS study, 2168 (74·5%) underwent respiratory polygraphy. For the 1810 participants with complete polygraphic data (mean age 46 years, SD 15; 1163 [64·2%] women), the prevalence of mild-to-severe SDB (AHI ≥5/h) was 43·2% (95% CI 40·9-45·5), of moderate-to-severe SDB (AHI ≥15/h) was 11·6% (10·2-13·1), and of severe SDB (AHI ≥30/h) was 2·7% (2·0-3·5). Factors independently associated with SDB were advanced age, male sex, large neck circumference, abdominal obesity, overweight or obesity, and snoring. After multivariable adjustment, severe SDB was independently associated with hypertension in women (odds ratio 3·99, 95% CI 1·04-15·33; ptrend=0·044), but not in men (odds ratio 0·67, 0·22-2·05; Ptrend=0·63).\u0000\u0000\u0000INTERPRETATION\u0000The BeSAS study provides the first large-scale objective evaluation of SDB prevalence and associated factors in Africa. The high prevalence of SDB identified should stimulate the development of public health policies to prevent and treat this condition in African countries.\u0000\u0000\u0000FUNDING\u0000Ligue Pulmonaire Vaudoise, Switzerland.","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"223 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122462158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis. 慢性鼻窦炎合并鼻息肉病的内科与外科联合治疗。
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00061-3
B. Lipworth, R. Chan, R. Misirovs, Kirsten E. Stewart
{"title":"Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis.","authors":"B. Lipworth, R. Chan, R. Misirovs, Kirsten E. Stewart","doi":"10.1016/s2213-2600(22)00061-3","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00061-3","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131778820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Respir Med 2022; published online March 29. https://doi.org/10.1016/S2213-2600(21)00537-3. 柳叶刀呼吸医学2022修正;3月29日在网上发表。https://doi.org/10.1016/s2213 - 2600(21) 00537 - 3。
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00128-x
{"title":"Correction to Lancet Respir Med 2022; published online March 29. https://doi.org/10.1016/S2213-2600(21)00537-3.","authors":"","doi":"10.1016/s2213-2600(22)00128-x","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00128-x","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"144 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133618049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treating COVID-19-related breathlessness with novel interventions 用新型干预措施治疗与covid -19相关的呼吸困难
Pub Date : 2022-04-01 DOI: 10.1016/S2213-2600(22)00161-8
E. Daynes
{"title":"Treating COVID-19-related breathlessness with novel interventions","authors":"E. Daynes","doi":"10.1016/S2213-2600(22)00161-8","DOIUrl":"https://doi.org/10.1016/S2213-2600(22)00161-8","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130373567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented COVID-19疫苗接种后心包炎:出乎意料但并非史无前例
Pub Date : 2022-04-01 DOI: 10.1016/S2213-2600(22)00091-1
Margaret Ryan, Jay R. Montgomery
{"title":"Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented","authors":"Margaret Ryan, Jay R. Montgomery","doi":"10.1016/S2213-2600(22)00091-1","DOIUrl":"https://doi.org/10.1016/S2213-2600(22)00091-1","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121503983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Correction to Lancet Respir Med 2022; published online Feb 25. https://doi.org/10.1016/S2213-2600(22)00045-5 柳叶刀呼吸医学2022修正;2月25日在网上发表。https://doi.org/10.1016/s2213 - 2600 (22) 00045 - 5
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00139-4
{"title":"Correction to Lancet Respir Med 2022; published online Feb 25. https://doi.org/10.1016/S2213-2600(22)00045-5","authors":"","doi":"10.1016/s2213-2600(22)00139-4","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00139-4","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124289206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long COVID: systemic inflammation and obesity as therapeutic targets 长冠:全身性炎症和肥胖作为治疗靶点
Pub Date : 2022-04-01 DOI: 10.1016/S2213-2600(22)00159-X
L. Florêncio, C. Fernández‐de‐las‐Peñas
{"title":"Long COVID: systemic inflammation and obesity as therapeutic targets","authors":"L. Florêncio, C. Fernández‐de‐las‐Peñas","doi":"10.1016/S2213-2600(22)00159-X","DOIUrl":"https://doi.org/10.1016/S2213-2600(22)00159-X","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115712672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
GETting to know the many causes and faces of COPD. 了解慢性阻塞性肺病的多种病因和面貌。
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00049-2
Hyun Lee, D. Sin
{"title":"GETting to know the many causes and faces of COPD.","authors":"Hyun Lee, D. Sin","doi":"10.1016/s2213-2600(22)00049-2","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00049-2","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122623782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Dynamic zero COVID policy in the fight against COVID 抗疫动态零冠策略
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00142-4
T. Burki
{"title":"Dynamic zero COVID policy in the fight against COVID","authors":"T. Burki","doi":"10.1016/s2213-2600(22)00142-4","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00142-4","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126427364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 43
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis - Authors' reply. 内科和外科联合治疗慢性鼻窦炎合并鼻息肉——作者的答复。
Pub Date : 2022-04-01 DOI: 10.1016/s2213-2600(22)00064-9
E. Lourijsen, S. Reitsma, G. Hannink, W. Fokkens
{"title":"Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis - Authors' reply.","authors":"E. Lourijsen, S. Reitsma, G. Hannink, W. Fokkens","doi":"10.1016/s2213-2600(22)00064-9","DOIUrl":"https://doi.org/10.1016/s2213-2600(22)00064-9","url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"255 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133224398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet. Respiratory medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1